Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Plos One
|
February 13, 2016
Effect of Ethanol on the Metabolic Characteristics of HIV-1 Integrase Inhibitor Elvitegravir and Elvitegravir/Cobicistat with CYP3A: An Analysis Using a Newly Developed LC-MS/MS Method
Narasimha M Midde, Mohammad A Rahman, Chetan Rathi, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
November 13, 2018
Dynamic time-kill curve characterization of spectinamide antibiotics 1445 and 1599 for the treatment of tuberculosis
Pavan K Vaddady, Ashit Trivedi, Chetan Rathi, et al.
Indian Heart Journal
|
February 10, 2020
Intermediate term outcome after electrogram guided segmental ostial pulmonary vein isolation using an 8 mm tip catheter for paroxysmal atrial fibrillation
Prashant Pawar, Ramalingam Vadivelu, Neeta Bachani, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 19, 2023
Longitudinal efficacy and safety modeling and simulation framework to aid dose selection of belantamab mafodotin for patients with multiple myeloma
Jon Collins, Martijn van Noort, Chetan Rathi, et al.
World Journal of Transplantation
|
April 5, 2024
Liver transplantation for hepatocellular carcinoma in India: Are we ready for 2040?
Hirak Pahari, Amruth Raj, Ambreen Sawant, et al.
Journal of Family Medicine and Primary Care
|
June 9, 2020
Esophageal carcinoma: An epidemiological analysis and study of the time trends over the last 20 years from a single center in India
Dhaval Choksi, Kailash M Kolhe, Meghraj Ingle, et al.
Tuberculosis (Edinburgh, Scotland)
|
February 4, 2019
Comparative pharmacokinetics of spectinamide 1599 after subcutaneous and intrapulmonary aerosol administration in mice
Chetan Rathi, Pradeep B Lukka, Santosh Wagh, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
February 22, 2025
Tutorial on Conditional Simulations With a Tumor Size-Overall Survival Model to Support Oncology Drug Development
Sebastiaan C Goulooze, Morris Muliaditan, Richard C Franzese, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
February 22, 2025
Development of a Joint Tumor Size-Overall Survival Modeling and Simulation Framework Supporting Oncology Development Decision-Making
Herbert Struemper, Chetan Rathi, Morris Muliaditan, et al.
Antimicrobial Agents and Chemotherapy
|
August 23, 2021
Model-Based Exposure-Response Assessment for Spectinamide 1810 in a Mouse Model of Tuberculosis
Santosh Wagh, Chetan Rathi, Pradeep B Lukka, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Plos One
|
February 13, 2016
Effect of Ethanol on the Metabolic Characteristics of HIV-1 Integrase Inhibitor Elvitegravir and Elvitegravir/Cobicistat with CYP3A: An Analysis Using a Newly Developed LC-MS/MS Method
Narasimha M Midde, Mohammad A Rahman, Chetan Rathi, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
November 13, 2018
Dynamic time-kill curve characterization of spectinamide antibiotics 1445 and 1599 for the treatment of tuberculosis
Pavan K Vaddady, Ashit Trivedi, Chetan Rathi, et al.
Indian Heart Journal
|
February 10, 2020
Intermediate term outcome after electrogram guided segmental ostial pulmonary vein isolation using an 8 mm tip catheter for paroxysmal atrial fibrillation
Prashant Pawar, Ramalingam Vadivelu, Neeta Bachani, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 19, 2023
Longitudinal efficacy and safety modeling and simulation framework to aid dose selection of belantamab mafodotin for patients with multiple myeloma
Jon Collins, Martijn van Noort, Chetan Rathi, et al.
World Journal of Transplantation
|
April 5, 2024
Liver transplantation for hepatocellular carcinoma in India: Are we ready for 2040?
Hirak Pahari, Amruth Raj, Ambreen Sawant, et al.
Journal of Family Medicine and Primary Care
|
June 9, 2020
Esophageal carcinoma: An epidemiological analysis and study of the time trends over the last 20 years from a single center in India
Dhaval Choksi, Kailash M Kolhe, Meghraj Ingle, et al.
Tuberculosis (Edinburgh, Scotland)
|
February 4, 2019
Comparative pharmacokinetics of spectinamide 1599 after subcutaneous and intrapulmonary aerosol administration in mice
Chetan Rathi, Pradeep B Lukka, Santosh Wagh, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
February 22, 2025
Tutorial on Conditional Simulations With a Tumor Size-Overall Survival Model to Support Oncology Drug Development
Sebastiaan C Goulooze, Morris Muliaditan, Richard C Franzese, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
February 22, 2025
Development of a Joint Tumor Size-Overall Survival Modeling and Simulation Framework Supporting Oncology Development Decision-Making
Herbert Struemper, Chetan Rathi, Morris Muliaditan, et al.
Antimicrobial Agents and Chemotherapy
|
August 23, 2021
Model-Based Exposure-Response Assessment for Spectinamide 1810 in a Mouse Model of Tuberculosis
Santosh Wagh, Chetan Rathi, Pradeep B Lukka, et al.
Page
of 4